Betta Pharmaceuticals Co Ltd Financial Flexibility Index
Betta Pharmaceuticals Co Ltd financial flexibility index. Betta Pharmaceuticals Co Ltd (300558) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥314.88 Million (operating CF CN¥224.45 Million minus capex CN¥90.43 Million) represents 0% of total liabilities (CN¥3.78 Billion). Explore 300558 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Betta Pharmaceuticals Co Ltd (2011–2025)
Financial flexibility index of Betta Pharmaceuticals Co Ltd from 2011 to 2025. Historical Financial Flexibility Index trend for Betta Pharmaceuticals Co Ltd across 15 annual periods. Check total reinvestment intensity of Betta Pharmaceuticals Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Betta Pharmaceuticals Co Ltd Financial Flexibility Index by Year (2011–2025)
Betta Pharmaceuticals Co Ltd financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Betta Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Betta Pharmaceuticals Co Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥1.53 Billion | CN¥911.26 Million | CN¥3.90 Billion | ▼ -17.1% |
| 2024 | 0.47x | CN¥1.74 Billion | CN¥911.17 Million | CN¥3.68 Billion | ▼ -10.7% |
| 2023 | 0.53x | CN¥2.01 Billion | CN¥914.23 Million | CN¥3.80 Billion | ▲ +18.7% |
| 2022 | 0.45x | CN¥1.32 Billion | CN¥306.74 Million | CN¥2.95 Billion | ▼ -44.9% |
| 2021 | 0.81x | CN¥1.29 Billion | CN¥526.63 Million | CN¥1.59 Billion | ▼ -33.3% |
| 2020 | 1.22x | CN¥1.33 Billion | CN¥646.02 Million | CN¥1.10 Billion | ▲ +72.0% |
| 2019 | 0.71x | CN¥1.18 Billion | CN¥555.07 Million | CN¥1.66 Billion | ▼ -0.8% |
| 2018 | 0.71x | CN¥901.23 Million | CN¥286.40 Million | CN¥1.27 Billion | ▼ -41.8% |
| 2017 | 1.22x | CN¥864.04 Million | CN¥278.26 Million | CN¥706.48 Million | ▼ -58.5% |
| 2016 | 2.94x | CN¥701.55 Million | CN¥407.05 Million | CN¥238.27 Million | ▲ +43.5% |
| 2015 | 2.05x | CN¥519.16 Million | CN¥385.56 Million | CN¥253.09 Million | ▼ -45.0% |
| 2014 | 3.73x | CN¥447.29 Million | CN¥277.55 Million | CN¥119.90 Million | ▲ +60.4% |
| 2013 | 2.33x | CN¥213.25 Million | CN¥190.34 Million | CN¥91.71 Million | ▲ +9.2% |
| 2012 | 2.13x | CN¥188.34 Million | CN¥149.29 Million | CN¥88.44 Million | ▲ +305.1% |
| 2011 | 0.53x | CN¥85.60 Million | CN¥34.80 Million | CN¥162.83 Million | — |